Analysts See $-0.55 EPS for NewLink Genetics (NLNK); Mairs & Power Raised Black Hills (BKH) Position

April 26, 2018 - By Adrian Erickson

NewLink Genetics Corporation (NASDAQ:NLNK) Logo

Analysts expect NewLink Genetics Corporation (NASDAQ:NLNK) to report $-0.55 EPS on May, 3.They anticipate $0.17 EPS change or 23.61% from last quarter’s $-0.72 EPS. After having $-0.37 EPS previously, NewLink Genetics Corporation’s analysts see 48.65% EPS growth. The stock increased 1.53% or $0.07 during the last trading session, reaching $4.66. About 105,717 shares traded. NewLink Genetics Corporation (NASDAQ:NLNK) has declined 65.28% since April 26, 2017 and is downtrending. It has underperformed by 76.83% the S&P500.

Mairs & Power Inc increased Black Hills Corp (BKH) stake by 24.24% reported in 2017Q4 SEC filing. Mairs & Power Inc acquired 35,340 shares as Black Hills Corp (BKH)’s stock declined 9.27%. The Mairs & Power Inc holds 181,110 shares with $10.89M value, up from 145,770 last quarter. Black Hills Corp now has $3.00B valuation. The stock increased 0.38% or $0.21 during the last trading session, reaching $55.95. About 46,010 shares traded. Black Hills Corporation (NYSE:BKH) has declined 19.28% since April 26, 2017 and is downtrending. It has underperformed by 30.83% the S&P500.

Among 6 analysts covering NewLink Genetics (NASDAQ:NLNK), 1 have Buy rating, 0 Sell and 5 Hold. Therefore 17% are positive. NewLink Genetics had 21 analyst reports since March 23, 2016 according to SRatingsIntel. The company was maintained on Thursday, June 8 by Jefferies. The stock of NewLink Genetics Corporation (NASDAQ:NLNK) earned “Buy” rating by Bank of America on Friday, March 2. The firm has “Buy” rating given on Friday, October 13 by Robert W. Baird. Stifel Nicolaus maintained NewLink Genetics Corporation (NASDAQ:NLNK) on Thursday, August 31 with “Buy” rating. The firm has “Outperform” rating by Robert W. Baird given on Wednesday, March 23. The firm has “Buy” rating by Stifel Nicolaus given on Monday, July 10. Bank of America downgraded the stock to “Hold” rating in Friday, April 6 report. The stock has “Hold” rating by SunTrust on Monday, April 9. The rating was downgraded by SunTrust on Wednesday, May 11 to “Neutral”. The company was upgraded on Friday, September 8 by Jefferies.

NewLink Genetics Corporation, a biopharmaceutical company, focuses on discovering, developing, and commercializing immunotherapeutic products for the treatment of cancer. The company has market cap of $173.15 million. The Company’s portfolio includes biologic product candidates based on its HyperAcute cellular immunotherapy technology, which is designed to stimulate the human immune system to attack cancer cells; and small-molecule product candidates that are focused on breaking the immune system's tolerance to cancer by inhibiting the indoleamine-2, 3-dioxygenase pathway and the tryptophan-2, 3-dioxygenase pathway. It currently has negative earnings. The firm is developing IDO pathway inhibitors comprising indoximod that is in multiple Phase I and Phase II clinical trials for patients with melanoma, pancreatic cancer, malignant brain tumors, metastatic breast cancer, acute myeloid leukemia, prostate cancer, and non-small cell lung cancer ; and GDC-0919 and atezolizumab (MPDL3280A) that is in Phase Ib clinical trials for patients with locally advanced or metastatic solid tumors.

Investors sentiment increased to 1.51 in 2017 Q4. Its up 0.29, from 1.22 in 2017Q3. It increased, as 22 investors sold NewLink Genetics Corporation shares while 21 reduced holdings. 28 funds opened positions while 37 raised stakes. 23.56 million shares or 27.79% more from 18.44 million shares in 2017Q3 were reported. State Board Of Administration Of Florida Retirement Sys stated it has 0% of its portfolio in NewLink Genetics Corporation (NASDAQ:NLNK). Virtu Financial Limited Liability Corp owns 98,385 shares or 0.04% of their US portfolio. Zurcher Kantonalbank (Zurich Cantonalbank) stated it has 0% in NewLink Genetics Corporation (NASDAQ:NLNK). New York-based Moore Capital Mngmt Limited Partnership has invested 0.01% in NewLink Genetics Corporation (NASDAQ:NLNK). Fenimore Asset Mngmt holds 0% of its portfolio in NewLink Genetics Corporation (NASDAQ:NLNK) for 12,321 shares. Millennium Mgmt Ltd Liability Corp reported 2.35 million shares. Dimensional Fund Advisors Lp has 0% invested in NewLink Genetics Corporation (NASDAQ:NLNK). Tiverton Asset Mgmt Ltd Liability has invested 0.02% in NewLink Genetics Corporation (NASDAQ:NLNK). Baker Bros Advsr L P stated it has 1.01 million shares. Connor Clark And Lunn Investment Mgmt Ltd has invested 0.02% in NewLink Genetics Corporation (NASDAQ:NLNK). Trexquant Invest Ltd Partnership holds 60,917 shares or 0.05% of its portfolio. California-based Redmile Grp Inc Ltd Liability has invested 0.74% in NewLink Genetics Corporation (NASDAQ:NLNK). The California-based Venbio Select Advisor Ltd Com has invested 0.42% in NewLink Genetics Corporation (NASDAQ:NLNK). Schwab Charles Inv Mngmt has 100,944 shares for 0% of their portfolio. Parallax Volatility Advisers Ltd Partnership holds 4,452 shares or 0% of its portfolio.

Investors sentiment increased to 1.28 in 2017 Q4. Its up 0.10, from 1.18 in 2017Q3. It increased, as 31 investors sold BKH shares while 61 reduced holdings. 43 funds opened positions while 75 raised stakes. 51.54 million shares or 2.92% more from 50.08 million shares in 2017Q3 were reported. Qci Asset Mngmt New York owns 100 shares. Belgium-based Kbc Group Inc Nv has invested 0% in Black Hills Corporation (NYSE:BKH). State Treasurer State Of Michigan reported 0.01% of its portfolio in Black Hills Corporation (NYSE:BKH). 31,025 are held by Us National Bank De. Principal Grp Inc Inc holds 0.01% or 225,874 shares in its portfolio. Hillcrest Asset Mgmt Limited Company holds 215,227 shares. Rocky Mountain Advisers Limited Liability accumulated 1,000 shares. Legal And General Grp Public Ltd Com has 0.01% invested in Black Hills Corporation (NYSE:BKH) for 231,628 shares. Alliancebernstein LP holds 1.13 million shares or 0.05% of its portfolio. Neuberger Berman Ltd Company has 0% invested in Black Hills Corporation (NYSE:BKH) for 13,008 shares. California Employees Retirement Systems stated it has 98,011 shares. Retail Bank Of Montreal Can holds 0% or 29,961 shares in its portfolio. Invesco Limited has invested 0.01% in Black Hills Corporation (NYSE:BKH). Zebra Mngmt reported 11,971 shares or 0.24% of all its holdings. Moreover, Teachers Retirement System Of The State Of Kentucky has 0.04% invested in Black Hills Corporation (NYSE:BKH) for 52,318 shares.

NewLink Genetics Corporation (NASDAQ:NLNK) Institutional Positions Chart

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Posts

>